Lifeloc Technologies GAAP EPS of -$0.03, revenue of $2.52M
Lifeloc Technologies reported Q3 GAAP EPS of -$0.03 and revenue of $2.52M, up 12.0% year-over-year, according to the company's press release.
How this was made
The 30-second read
Why it matters
Traders can update near-term expectations for profitability trajectory based on the reported loss and revenue growth, but the lack of guidance limits forward positioning.
Market read
A fresh quarterly earnings datapoint for LCTC, highlighting continued GAAP losses despite year-over-year revenue growth.
What to watch
No guidance, cash flow, backlog, gross margin, or expense trend is provided, which are often the key drivers of post-earnings repricing.
Background
The piece summarizes Lifeloc Technologies’ Q3 earnings release with GAAP EPS and revenue figures.
Ticker impact
Article reports Lifeloc Technologies Q3 GAAP EPS of -$0.03 and revenue of $2.52M, a direct earnings datapoint for the stock.
Likely downside or volatility as traders weigh continued losses against the reported revenue growth.
The only disclosed figures are GAAP EPS and revenue; without guidance or segment detail, the market reaction typically hinges on whether losses are narrowing, which is not provided here.
Market effects
Limited read-through because the article provides no peer or sector context beyond a single small-cap healthcare/medical device earnings print.
None indicated.
None indicated.
Counterpoint
Revenue growth (+12% Y/Y) could be viewed as early traction, and the GAAP loss may reflect non-cash charges or investment spending not captured by operating cash flow.
Key entities
- companyLifeloc Technologies, Inc.
Subject of the earnings report, with Q3 GAAP EPS of -$0.03 and revenue of $2.52M (+12% Y/Y).


